
ABRE™: Adaptive Biothreat Response Ecosystem
Biosecurity Intelligence Infrastructure
ABRE™: Adaptive Biothreat Response Ecosystem
Biosecurity Intelligence Infrastructure

Biosecurity Intelligence Infrastructure
Biosecurity Intelligence Infrastructure
ABRE™ Adaptive Biothreat Response Ecosystem is a biosecurity intelligence infrastructure platform designed to support early warning, predictive modeling, and decision support across human health, animal health, food supply, and pharmaceutical readiness. ABRE was developed to help government, defense, healthcare, agriculture, and critical infrastructure stakeholders better understand emerging biological risks, model potential downstream impacts, and improve preparedness before disruptions escalate.

Biological threats do not affect only one sector at a time. A disease event in livestock, a disruption in food production, a pharmaceutical supply chain shortage, or an emerging human-health outbreak can quickly cascade into broader public health, economic, operational, and national security consequences. Today, many systems remain fragmented across agencies, industries, data sources, and response functions, limiting the ability of decision-makers to detect weak signals early, understand cross-sector impacts, and act before a crisis becomes widespread.

ABRE™ is designed to connect siloed data signals across biological risk, agriculture, animal health, food systems, pharmaceutical supply chains, logistics, and operational readiness into a unified decision-support environment. Its core capabilities include early warning, predictive modeling, scenario simulation, supply chain resilience analysis, and mission-specific dashboards that help users assess risk, forecast impacts, and support faster, more informed decisions.

ABRE™ is aligned with emerging national and global priorities in health security, agriculture biosecurity, food supply defense, pharmaceutical resilience, defense readiness, and healthcare system continuity. The platform is designed to be configurable across multiple mission areas while preserving data governance, customer control, and mission-specific deployment requirements.

ABRE™ converts insight into action by delivering decision-ready playbooks aligned to real-world operational constraints in the fields of biotechnology and defense technology. These playbooks are designed to support rapid alignment, coordinated response, and deliberate execution within the context of national security, reducing decision latency and minimizing improvisation during high-consequence events, such as biothreat scenarios. The focus is not simply on awareness, but on actionable strategies that integrate seamlessly with Healthcare Technology initiatives.
Copyright © 2026 USAPI Pharma, PBC. All Rights Reserved. USAPI Pharma, PBC develops ABRE™, a biosecurity intelligence infrastructure platform focused on national readiness, human and animal health security, food supply defense, and pharmaceutical supply chain resilience.. Information on this site is for general informational purposes only and does not imply or constitute any partnership, approval, or endorsement by the U.S. Government or its agencies. Unauthorized reproduction or distribution is prohibited.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.